A summary of these findings and the main efficacy indicators and mechanisms are summarized in Table 1 and Figure 5
(dpcj.org) Yes reported severe adverse events (e.g., SJS, SIRS) have occurred after combined IV formulations
As ACSL4 increases PUFA concentrations in cell membranes [21], ACSL4 upregulation has been hypothesized to contribute to the observed lipid peroxidation, morphological changes, and cell death among irradiated cells [20, 35]
The transcellular crossing of the epithelium exploits different components of the host intracellular trafficking system
6-Phosphogluconolactonase: PGLS The product of the glucose-6-phosphate dehydrogenase reaction, 6-phosphogluconolactone, is converted to 6-phosphogluconate by the enzyme, 6-phosphogluconolactonase which is encoded by the PGLS gene